These compounds may interact with:
5-hydroxytryptamine receptor 3B
Potentially involved in: heroin dependence; irritable bowel syndrome; alcohol dependence; schizophrenia; nicotine dependence; alcoholic intoxication, chronic; bipolar disorder; mental depression; depressive disorder; myopathy; pain; unipolar depression; major depressive disorder; ovarian cancer; psoriasis; muscular diseases; chemotherapy-induced nausea and vomiting; intubation of gastrointestinal tract; prevention of post-operative nausea and vomiting; post-operative nausea and vomiting
Disease data sourced from Pharos.